0000891293-19-000002.txt : 20190103 0000891293-19-000002.hdr.sgml : 20190103 20190103163110 ACCESSION NUMBER: 0000891293-19-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEELEY BRUCE J. CENTRAL INDEX KEY: 0001474462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28386 FILM NUMBER: 19506003 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-12-31 0 0000891293 CTI BIOPHARMA CORP ctic 0001474462 SEELEY BRUCE J. 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 0 1 0 0 EVP, Chief Operating Officer Common Stock 2018-12-31 4 A 0 500 0.6236 A 32000 D Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan. Bruce J. Seeley 2018-12-31